The Analyst Landscape: 13 Takes On Edwards Lifesciences
The Analyst Landscape: 13 Takes On Edwards Lifesciences
分析師視角下的愛德華生命科學：13種看法
13 analysts have expressed a variety of opinions on Edwards Lifesciences (NYSE:EW) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的季度裏，有13名分析師對愛德華生命科學(NYSE: EW)發表了各種不同的意見，提供了從看好到看淡的不同意見。
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
以下表格概括了他們最近的評級，展示了過去30天內的情緒演變並與之前的幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $96.23, a high estimate of $107.00, and a low estimate of $85.00. Surpassing the previous average price target of $90.75, the current average has increased by 6.04%.
分析師12個月的目標價格揭示了平均目標96.23美元，最高預估107.00美元和最低預估85.00美元。目前的平均價格目標高於以前的90.75美元，增長了6.04%。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
The perception of Edwards Lifesciences by financial experts...
通過最近的分析師...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。